TP53 and lung adenocarcinoma: NFκB activity increased in p53-null mice and p53 loss increased NFκB activation in a mouse model of KrasG12D-driven lung adenocarcinoma, while restoring p53 in p53-null lung tumors was found to inhibit NFκB, suppressing tumor growth [88,89].